Q3 2021
Released Oct 27, 2021, after the close
10-Q filed Oct 28, 2021, 28 days after period end · 0001653477-21-000065
Q3 2021 · 10-Q
Revenue$376.80M$376.80M +13.6% vs Q3 2020+5.1% vs Q2 2021
Net Income-$4.20M-$4.20M N/M vs Q3 2020N/M vs Q2 2021
EPS Diluted-$0.11-$0.11 N/M vs Q3 2020N/M vs Q2 2021
Gross Profit$141,800,000+1.6%
Operating Income$119,500,000−6.3%
Operating Cash Flowderived$100,100,000+11.2%
Free Cash Flowderived$74,600,000+1.5%
Margins · derived
Gross margin37.6%−4.5 pt vs Q3 2020
Operating margin31.7%−6.8 pt vs Q3 2020
Net margin-1.1%−22.2 pt vs Q3 2020
What the release said
The release
Same quarter
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Revenue | $376.80M | $331.70M | $359.90M | $311.20M |
| Net Income | -$4.20M | $69.90M | $59.90M | $49.50M |
| EPS Diluted | -$0.11 | $1.69 | $1.41 | $1.16 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR